MedPath

Building Emotional Self-Awareness Teletherapy (BEST)

Not Applicable
Completed
Conditions
Concussion, Mild
Concussion, Brain
Concussion, Intermediate
Concussion; Syndrome
Concussion Injury of Cerebrum
Concussion, Severe
Concussion with Brief Loss of Consciousness
Alexithymia
Interventions
Behavioral: Treatment
Registration Number
NCT05623046
Lead Sponsor
Indiana University
Brief Summary

To examine the feasibility, acceptability, and preliminary efficacy of a remotely delivered intervention for civilians and service members with mild traumatic brain injury (mTBI) who have difficulty recognizing and regulating their emotions. Post-treatment outcomes of interest include emotional self-awareness and regulation, resiliency, and affective symptoms.

Detailed Description

This Phase I proof of principle pilot study of the Building Emotional Self-awareness Teletherapy (BEST) intervention will use a quasi-experimental, non-randomized, one-group pretest-posttest design with a double pretest and a 3-month follow-up in approximately 40 participants with mTBI (\~20 civilians and \~20 service members). Study objectives are to explore the feasibility and early efficacy of BEST to improve psychological health outcomes in civilian and Service Member (SM) participants with mTBI who have alexithymia (poor emotional self-awareness) and emotion dysregulation. We anticipate BEST will have good feasibility and acceptability in both civilian and service member participants, and post-treatment assessments will show significant improvements in alexithymia, emotion regulation, resiliency, and affective symptoms.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Mild TBI (determined by Ohio State University TBI Identification Method)
  • ≥18 years old
  • U.S. resident (exclusion for California residents)
  • ≥6 months post-TBI
  • elevated alexithymia and emotion dysregulation (defined by >.5 standard deviation above means on the TAS-20 and DERS)
  • capacity to consent
  • proficient English
  • if on medications that influence affect, must be stable for at least 6 weeks
  • access to a device capable of video conferencing and high speed internet.
Exclusion Criteria
  • Premorbid neurological disorder other than TBI (e.g., stroke), active or uncontrolled major psychiatric disorder and/ or disorder that would pose a safety concern (e.g., borderline personality disorder)
  • degenerative neurologic condition
  • visual, hearing, communication, or cognitive impairments that would impede participation
  • unstable or anticipated medication changes that will influence mood/ affect during study participation
  • active involvement in an intensive rehabilitation program
  • individuals who recently started psychotherapy (e.g., < 3 months ago)
  • participant behaviors that cause concern for their ability to participate in accordance with the study requirements and protocol (e.g., unreliable correspondences, no-shows, no-replies to multiple contacts, habitual rescheduling, unable to complete study requirements in timely manner)
  • concurrent participation in any other clinical trial that aims to improve mood/ behavioral functioning will be an exclusion criterion.
  • participants will be excluded if at any point, they participated in TREAT (in-person clinical trial of BEST - NCT03414463)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TreatmentTreatment8 one-on-one teletherapy training sessions to enhance emotional skills. Teletherapy sessions will last approximately 60-90 minutes.
Primary Outcome Measures
NameTimeMethod
Change in Toronto Alexithymia Scale-20 (TAS-20)Baseline, Week 6, Week 12, Week 24

This is a 20-item self report questionnaire comprised of three sub-constructs (Difficulty Identifying feelings, Difficulty Describing feelings, Externally-oriented Thinking). The full scale range is 20-100 (higher scores indicate higher (worse) alexithymia). Subscales are summed to compute a total score.

Secondary Outcome Measures
NameTimeMethod
Change in Levels of Emotional Awareness Scale (LEAS)Baseline, Week 6, Week 12, Week 24

Objective, performance-based measure of emotional awareness and labeling. Short hypothetical scenarios are presented and participants are asked to describe how they and others would feel in the context of the scenarios. More discrete emotions earn more points (e.g., "sad" scores better than "bad"). Participants' responses are scored with an electronic system, removing human bias and interpretation. The LEAS has parallel forms (A and B), which will alternate at testing sessions.

Change in Difficulty with Emotion Regulation Scale (DERS)Baseline, Week 6, Week 12, Week 24

Using a 5-point Likert scale, participants rate the frequency they utilize self-regulation behaviors in response to general emotional distress. There are 6 subscales: Lack of Emotional Awareness; Lack of Emotional Clarity; Difficulties Controlling Impulsive Behaviors when Distressed; Difficulties Engaging in Goal-Directed Behavior when Distressed; Non-acceptance of Negative Emotional Responses; and Limited Access to Effective Emotion Regulation Strategies. Items are summed to provide a Total Emotion Dysregulation score. Scores range from 5 (low) to 180 (high). Higher scores are indicative of more emotion dysregulation problems. The DERS has high internal consistency, test-retest reliability, and good construct validity.

Trial Locations

Locations (1)

Indiana University

🇺🇸

Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath